Niu Liwen, Wang Xiaohong, Li Jun, Huang Yan, Yang Zhen, Chen Feihu, Ni Hongchang, Jin Yong, Lu Xiongwen, Cao Qi
School of Pharmacy, Anhui Medical University, Anhui Province, China.
Liver Int. 2007 Nov;27(9):1265-72. doi: 10.1111/j.1478-3231.2007.01582.x.
BACKGROUND/AIMS: Leptin has been recognized as a profibrogenic hormone in the liver and is involved in collagen type I formation by activated hepatic stellate cells (HSCs) in response to fibrogenic substances, but the molecular signal mechanisms by which leptin promotes liver fibrogenesis through upregulation of collagen type I expression is not clear. We investigated whether leptin-induced collagen type I is mediated by the Janus kinase-phosphatidylinositol 3-kinase-Akt (JAKs-PI3K-Akt) pathway in a human HSC cell line, LX-2.
LX-2 cells were treated with or without various inhibitors in the presence of leptin.
Leptin increased alpha1(I) collagen mRNA and protein. JAK1, PI3K and Akt were activated after leptin stimulation. AG490, a JAK inhibitor, blocked JAK1 phosphorylation accompanied by inhibition of PI3K and Akt activation as well as alpha1(I) collagen mRNA expression, indicating a JAK1-dependent mechanism. Wortmannin, a PI3K inhibitor, prevented PI3K and Akt activation and resulted in suppression of alpha1(I) collagen mRNA expression, suggesting a PI3K-mediated process. These changes were reproduced by overexpression of the dominant-negative p85alpha mutant. A443654.3, an Akt inhibitor, opposed Akt activation, leading to downregulation of alpha1(I) collagen mRNA. Overexpression of the dominant-negative Akt mutant led to similar alterations.
Leptin has a direct action on liver fibrogenesis by stimulating alpha1(I) collagen production in activated HSC. The process appears to be mediated by the PI3K/Akt pathway through activated JAK1.
背景/目的:瘦素已被公认为肝脏中的促纤维化激素,可通过激活的肝星状细胞(HSCs)响应纤维化物质参与I型胶原蛋白的形成,但瘦素通过上调I型胶原蛋白表达促进肝纤维化的分子信号机制尚不清楚。我们研究了在人HSC细胞系LX-2中,瘦素诱导的I型胶原蛋白是否由Janus激酶-磷脂酰肌醇3-激酶-Akt(JAKs-PI3K-Akt)途径介导。
在存在瘦素的情况下,用或不用各种抑制剂处理LX-2细胞。
瘦素增加了α1(I)型胶原蛋白的mRNA和蛋白质水平。瘦素刺激后JAK1、PI3K和Akt被激活。JAK抑制剂AG490阻断JAK1磷酸化,同时抑制PI3K和Akt激活以及α1(I)型胶原蛋白mRNA表达,表明这是一种依赖JAK1的机制。PI3K抑制剂渥曼青霉素可阻止PI3K和Akt激活,并导致α1(I)型胶原蛋白mRNA表达受到抑制,提示这是一个由PI3K介导的过程。这些变化可通过显性负性p85α突变体的过表达重现。Akt抑制剂A443654.3可对抗Akt激活,导致α1(I)型胶原蛋白mRNA下调。显性负性Akt突变体的过表达导致类似的改变。
瘦素通过刺激活化的HSC中α1(I)型胶原蛋白的产生对肝纤维化有直接作用。这一过程似乎是通过激活的JAK1由PI3K/Akt途径介导的。